Cardiac troponin (ctn) testing is an
|
|
- Abner Shields
- 5 years ago
- Views:
Transcription
1 CLINICIAN UPDATE How to Interpret Elevated Cardiac Troponin Levels Vinay S. Mahajan, MD, PhD; Petr Jarolim, MD, PhD Cardiac troponin (ctn) testing is an essential component of the diagnostic workup and management of acute coronary syndromes (ACS). Although over the past 15 years the diagnostic performance of the previous gold-standard assay, creatine kinase- MB, has not changed appreciably, the ever-increasing sensitivity of ctn assays has had a dramatic impact on the use of ctn testing to diagnose ACS. 1 Here, we present 3 recent clinical cases from the emergency department with acute chest discomfort that exemplify the challenges introduced by highsensitivity ctn assays: a 48-year-old man who presented to the emergency department with chest discomfort lasting 2 hours and a 3-day history of flu-like symptoms whose ECG showed diffuse ST-segment changes, a 60- year-old woman with a medical history of heart failure who presented to the emergency department with chest pain lasting 1.5 hours whose ECG was nondiagnostic, and a 54-year-old man with a medical history of diabetes mellitus who presented with chest discomfort lasting 1 hour whose ECG was normal. Cardiac troponin I (ctni) testing (TnI- Ultra assay on the ADVIA Centaur XP immunoanalyzer, both Siemens Healthcare Diagnostics) was ordered on all 3 patients. The laboratory results were reported as positive in all 3 cases, with the reported values being 0.05, 0.06, and 0.06 ng/ml, respectively, all just above the diagnostic limit of 0.04 ng/ml. Assays for ctn, namely ctni and cardiac troponin T (ctnt), are the preferred diagnostic tests for ACS, in particular non ST-segment elevation myocardial infarction, because of the tissue-specific expression of ctni and ctnt in the myocardium. The results of ctn testing often guide the decision for coronary intervention. However, although the increasing sensitivity of ctn assays lowers the number of potentially missed ACS diagnoses, it presents a diagnostic challenge because the gains in diagnostic sensitivity have inevitably come with a decrease in specificity. For instance, the replacement of the ctn assay (Siemens Healthcare Diagnostics) by the more sensitive TnI-UItra assay in the Brigham and Women s Hospital Clinical Laboratories in early 2007 resulted in a doubling of positive ctn results in samples collected in the emergency department 2 even though there was no change in the frequency of final diagnoses of ACS. What Is a High-Sensitivity Troponin Test? Rapid advances in immunoassay technologies and the international adoption of traceable troponin calibration standards have allowed manufacturers to develop and calibrate troponin assays with unprecedented analytic sensitivity and precision. Thus, a contemporary ctni assay such as TnI-Ultra detects plasma ctn levels as low as ng/ml with an assay range that spans 4 orders of magnitude ( ng/ ml). Similarly, the limit of detection of a contemporary ctnt assay (Elecsys TnT-hs, Roche Diagnostics; approved for clinical use in Europe but not yet in the United States) is as low as ng/ml. 3 Although ctni and ctnt concentrations correlate to some extent, the numeric values can be quite different in a given patient, with ctnt readings generally being lower. Between 1995 and 2007, the limit of detection fell from 0.5 ng/ml for some ctn assays to ng/ml for TnI- Ultra, an 100-fold improvement in analytic sensitivity (Figure 1). Remarkably, the use of contemporary high-sensitivity ctn assays makes it possible to detect low levels of ctn even in plasma from healthy subjects. Indeed, high-sensitivity ctn assays are designated as such on the basis of their ability to detect ctns even in healthy individuals. The latest generation of high-sensitivity ctn assays can detect ctn in 95% of a reference popula- From the Brigham and Women s Hospital, Harvard Medical School, Boston, MA. Correspondence to Petr Jarolim, MD, PhD, Brigham and Women s Hospital, 75 Francis St, Boston, MA pjarolim@partners.org (Circulation. 2011;124: ) 2011 American Heart Association, Inc. Circulation is available at DOI: /CIRCULATIONAHA
2 Mahajan and Jarolim Interpretation of Elevated Troponin Levels 2351 Figure 1. Evolution of the cardiac troponin (ctn) assays and their diagnostic cutoffs. A hypothetical case of acute coronary syndrome is depicted with the earliest times of potential diagnosis corresponding to the diagnostic cutoffs of more sensitive ctn assays. The years correspond to the availability of the respective assays in the US market. tion. 4 The ability to detect ctns in healthy individuals made it imperative to define a clinical decision limit for ctn concentration, ie, a positive ctn result. What Is a Positive Troponin Result? The 99th Percentile Rule The National Academy of Clinical Biochemistry issued a guideline in 2007 that stated that in the presence of a clinical history suggestive of ACS, the following is considered indicative of myocardial necrosis consistent with myocardial infarction: maximal concentration of ctn exceeding the 99th percentile of values (with optimal precision defined by total c.v. [coefficient of variation] 10%) for a reference control group on at least one occasion during the first 24 hours after the clinical event. 5 This guideline provides the framework for determining the decision limit or a positive troponin result. Based on the 99th percentile rule, troponin decision limits of several high-sensitivity ctn assays can be set as low as 0.01 ng/ml. 6 This makes it possible to identify patients with ACS earlier, enabling earlier coronary intervention (Figure 2). However, while improving clinical sensitivity for the diagnosis of myocardial infarction, the
3 2352 Circulation November 22, 2011 Figure 2. Cardiac troponin I (ctni) levels in a healthy reference population and in an acute coronary syndrome (ACS) population. Top, Frequency histograms of real TnI levels (blue filled) in healthy reference controls are shown, along with the distribution of the same TnI levels as measured with a less precise ctni (green) and the more precise TnI- Ultra (blue) assay for comparison. In practice, the values below the assay detection threshold (dashed portions of the histogram plots) cannot be distinguished from one another. Note how the 99th percentile decision limits decrease with increased assay precision. Bottom, Hypothetical frequency histograms of ctni concentrations in individuals with ACS 2, 2 to 3, or 3 to 4 hours after the onset of symptoms. The decision limits (dashed vertical lines) for the contemporary high-sensitivity ctni assays are based on the 99th percentile in a healthy reference population. Note the impact of decreased diagnostic cutoffs of the newer ctni assays on the fraction of acute myocardial infarctions diagnosed at earlier time intervals. (All frequency histograms in this figure are hypothetical and for illustrative purposes only.) increased analytic sensitivity has come at the cost of reduced specificity, thus presenting an additional diagnostic challenge for clinicians. The Specificity of a Troponin Test for ACS The use of the 99th percentile cutoff for ctn positivity does not imply that 1% of the population suffers from myocardial damage. Rather, this cutoff is useful only when applied to patients with a high pretest probability of ACS. The clinician must interpret ctn results in the context of clinical history, ECG findings, and possibly cardiac imaging to establish the correct diagnosis. A positive troponin in the setting of a low pretest probability for ACS may be suggestive but clearly is not indicative of a coronary event. Unfortunately, the pressure to avoid malpractice litigation forces many clinicians to order comprehensive panels of laboratory tests, including ctn, for patients with a very low pretest probability of ACS, which adversely affects the positive predictive value of ctn assays for diagnosing myocardial infarction. Traditional wisdom, before the advent of high-sensitivity ctn assays, held that troponins do not appear in the circulation of individuals with a healthy myocardium. These levels used to be considered indicative of myocardial necrosis. However, with high-sensitivity troponin assays, circulating ctnt or ctni can be found in the plasma as a result of transient ischemic or inflammatory myocardial injury. Thus, elevated ctn may be detected in conditions other than ACS (the Table), including heart failure, cardiomyopathies, myocarditis, renal failure, tachyarrhythmias, and pulmonary embolism, and even after strenuous exercise in healthy individuals. 8 The Need for Serial Troponin Testing In addition to the absolute level of ctn in plasma or serum above the decision limit, a critical component of the diagnosis of ACS is ctn kinetics. This was reiterated in the current universal definition of myocardial infarction adopted in Although absolute ctn elevations are seen in multiple chronic cardiac and noncardiac conditions, a rise or fall in serial ctn levels strongly supports an acutely evolving cardiac injury such as, most commonly, acute myocardial infarction. Serial ctn testing helped establish final diagnoses in our 3 patients. Patient 1 (Figure 3, top) had a steady but relatively slow increase in ctni with a peak value of 0.9 ng/ml. The findings of acute dilated cardiomyopathy and global ventricular dysfunction on echocardiography were consistent with a diagnosis of acute myocarditis. Patient 2 (Figure 3, middle) had modest ctn elevations fluctuating just above the decision limit in the 0.05 to 0.09 ng/ml range. She was diagnosed with acutely decompensated heart fail-
4 Mahajan and Jarolim Interpretation of Elevated Troponin Levels 2353 Table. Causes of Elevated Plasma Cardiac Troponin Other Than Acute Coronary Syndromes Cardiac Causes Noncardiac Causes Cardiac contusion resulting from trauma Pulmonary embolism Cardiac surgery Severe pulmonary hypertension Cardioversion Renal failure Endomyocardial biopsy Stroke, subarachnoid hemorrhage Acute and chronic heart failure Infiltrative diseases, eg, amyloidosis Aortic dissection Cardiotoxic drugs Aortic valve disease Critical illness Hypertrophic cardiomyopathy Sepsis Tachyarrhythmia Extensive burns Bradyarrhythmia, heart block Extreme exertion Apical ballooning syndrome Post percutaneous coronary intervention Rhabdomyolysis with myocyte necrosis Myocarditis or endocarditis/pericarditis Adapted from Jaffe et al 7 with permission of the publisher. Copyright 2006, Elsevier. Figure 3. Troponin kinetics in the index cases. Plasma cardiac troponin I (ctni) values in the 3 index cases. The cutoff for the TnI assay (0.04 ng/ml) is indicated with a dashed horizontal line. See the text for detailed description. ure. Additional TnI testing did not provide evidence of ACS. TnI levels in patient 3 (Figure 3, bottom) rose to a peak of 53 ng/ml within 24 hours. He was diagnosed with non ST-segment elevation myocardial infarction when the second ctn result of 6.3 ng/ml was obtained after 6 hours. The rapid, steep increase from the initial barely positive value of 0.06 ng/ml to the 6-hour value of 6.3 ng/ml illustrates that more frequent testing during the first several hours may be sufficient to detect a diagnostic rise in ctn levels that is eventually destined to increase by a few orders of magnitude such as the peak of 53 ng/ml in this patient. Fortunately, simultaneous improvements in contemporary assay sensitivity and precision allow 2 ctn values with a difference as small as a few hundredths of 1 ng/ml to be distinguished reliably. This has significant implications for serial ctn testing. Previously, clinicians often had to wait an average of 6 hours with the lower-sensitivity, lower-precision ctn assays to see a conclusive increase in plasma ctn levels after the first troponin measurement, but today s highsensitivity ctn tests that are separated by a mere 2 to 3 hours can be highly informative. Given the urgent need for early diagnosis of ACS and appropriate emergency intervention, as well as the ease of performing this relatively inexpensive assay, clinicians do not need to wait 6 to 8 hours before ordering a second troponin test to rule in ACS. We recommend collecting a second specimen for ctn testing within 2 to 3 hours from the collection of the blood sample at presentation to help confirm the diagnosis of MI. Conclusions Commenting on the ever-increasing sensitivity and decreasing specificity of ctn assays, Robert Jesse quipped, When troponin was a lousy assay it was a great test, but now that it s becoming a great assay, it s getting to be a lousy test. 9 However, frequent monitoring of ctn kinetics, along with
5 2354 Circulation November 22, 2011 careful attention to the noncoronary causes of ctn elevations, will keep the high-sensitivity ctn assays in the class where they rightfully belong among the greatest, most useful assays in clinical chemistry laboratories. Disclosures Dr Jarolim has research grants from Roche Diagnostics, Siemens Healthcare Diagnostics, Ortho Clinical Diagnostics, Beckman Coulter, Inc, and Amgen, as well as honoraria from Ortho Clinical Diagnostics and Roche Diagnostics. Dr Mahajan reports no conflicts. References 1. Melanson SEF, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol. 2007;128: Melanson SEF, Conrad MJ, Mosammaparast N, Jarolim P. Implementation of a highly sensitive cardiac troponin I assay: test volumes, positivity rates and interpretation of results. Clin Chim Acta. 2008;395: Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, Giannitsis E, Gustafson S, Handy B, Katus H, Melanson SE, Panteghini M, Venge P, Zorn M, Jarolim P, Bruton D, Jarausch J, Jaffe AS. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011;412: Apple FS. A new season for cardiac troponin assays: it s time to keep a scorecard. Clin Chem. 2009;55: Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández- Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N. Universal definition of myocardial infarction. Circulation. 2007;116: Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AHB, Jaffe AS. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem. 2005;51: Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol. 2006;48: Mingels AMA, Jacobs LHJ, Kleijnen VW, Laufer EM, Winkens B, Hofstra L, Wodzig WK, van Dieijen-Visser MP. Cardiac troponin T elevations, using highly sensitive assay, in recreational running depend on running distance. Clin Res Cardiol. 2010;99: Jesse RL. On the relative value of an assay versus that of a test: a history of troponin for the diagnosis of myocardial infarction. JAm Coll Cardiol. 2010;55:
About OMICS International
About OMICS International OMICS International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International hosts over 700
More informationTests I Wish You Had Not Ordered. Scott Girard D.O. FACOI Hospitalist
Tests I Wish You Had Not Ordered Scott Girard D.O. FACOI Hospitalist Disclosures None No company or person has decided to pay me to be here, give this talk, or want me to represent them in any way. Who
More informationSupplemental Material
Supplemental Material Table of Contents Supplemental Methods... 2 Details on exclusion criteria... 2 Use of hs-ctnt for adjudication of final diagnoses... 2 Assumption of Linearity... 3 Investigational
More informationOverall Changes of the Universal Myocardial Infarction Definition
Overall Changes of the Universal Myocardial Infarction Definition Professor Kristian Thygesen, FESC, FACC, FAHA Aarhus University Hospital, Aarhus, DK Co-Chairman of The Global MI Task Force Declaration
More informationCoronary Heart Disease
Coronary Heart Disease Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction Tobias Reichlin, MD*; Affan Irfan, MD*; Raphael
More informationEDUCATIONAL COMMENTARY CARDIAC FUNCTION: BIOCHEMICAL MARKERS UPDATE
EDUCATIONAL COMMENTARY CARDIAC FUNCTION: BIOCHEMICAL MARKERS UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE
More informationHigh Sensitivity Troponins. IT S TIME TO SAVE LIVES. Updates from the ESC 2015 Guidelines November 17th 2016 OPL CONGRESS Dr.
High Sensitivity Troponins. IT S TIME TO SAVE LIVES. Updates from the ESC 2015 Guidelines November 17th 2016 OPL CONGRESS Dr. Marcel El Achkar Chairperson of Laboratory department Nini Hospital Lecturer
More informationImpact of Troponin Performance on Patient Care
Impact of Troponin Performance on Patient Care Linda C, Rogers PhD, DABCC, FACB Agenda Introduction Diagnosis of MI Guidelines Troponin Assay differences Classification of troponin assays Guideline acceptable
More informationPharmacologyonline 2: (2010) Newsletter Kakadiya and Shah
ROLE OF CREATINE KINASE MB AND LACTATE DEHYDROGENASE IN CARDIAC FUNCTION A REVIEW Jagdish Kakadiya*, Nehal Shah Department of Pharmacology, Dharmaj Degree Pharmacy College, Petlad- Khambhat Road, Dharmaj,
More informationDocument Version Publisher s PDF, also known as Version of Record (includes final page, issue and volume numbers)
Variation of cardiac troponin I and T measured with sensitive assays in emergency department patients with noncardiac chest pain Scharnhorst, V.; Krasznai, K.; van 't Veer, M.; Michels, R.H. Published
More informationThe Universal Definition of Myocardial Infarction 3 rd revision, 2012
The Universal Definition of Myocardial Infarction 3 rd revision, 2012 Joseph S. Alpert, MD Professor of Medicine, University of Arizona College of Medicine, Tucson, AZ; Editor-in-Chief, American Journal
More informationPapers in Press. Published March 23, 2007 as doi: /clinchem
Papers in Press. Published March 23, 2007 as doi:10.1373/clinchem.2006.084715 The latest version is at http://www.clinchem.org/cgi/doi/10.1373/clinchem.2006.084715 Clinical Chemistry 53:4 547 551 (2007)
More informationCardiac Troponin Testing and Chest Pain Patients: Exploring the Shades of Gray
Cardiac Troponin Testing and Chest Pain Patients: Exploring the Shades of Gray Nichole Korpi-Steiner, PhD, DABCC, FACB University of North Carolina Chapel Hill, NC Learning Objectives Describe the acute
More informationDoes serial troponin measurement help identify acute ischemia/ischemic events?
Does serial troponin measurement help identify acute ischemia/ischemic events? Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine and Laboratory Medicine & Pathology
More informationSupplementary Online Content
Supplementary Online Content Rubini Giménez M, Twerenbold R, Boeddinghaus J, et al. Clinical effect of sex-specific cutoff values of high-sensitivity cardiac troponin T in suspected myocardial infarction.
More informationRapid detection of myocardial infarction with a sensitive troponin test Scharnhorst, V.; Krasznai, K.; van 't Veer, M.; Michels, R.
Rapid detection of myocardial infarction with a sensitive troponin test Scharnhorst, V.; Krasznai, K.; van 't Veer, M.; Michels, R. Published in: American Journal of Clinical Pathology DOI: 10.1309/AJCPA4G8AQOYEKLD
More informationA New Generation of Biomarkers Tests of Myocardial Necrosis: The Real Quality a Physician can get from the Laboratory
e-issn 1643-3750 DOI: 10.12659/MSM.892033 Received: 2014.07.18 Accepted: 2014.08.14 Published: 2015.01.28 A New Generation of Biomarkers Tests of Myocardial Necrosis: The Real Quality a Physician can get
More informationNon-Ischemic Causes of Troponin Elevation: Getting It Right. March 28, 2015
Non-Ischemic Causes of Troponin Elevation: Getting It Right March 28, 2015 WHY discuss this...? Misconceptions about meaning of elevated troponin Validation of troponin when utilized properly Prognostic
More informationThe Clinical Laboratory Working with Physicians to Improve Patient Care
The Clinical Laboratory Working with Physicians to Improve Patient Care Michael A. Pesce, PhD Professor Emeritus Columbia University Medical Center Department of Pathology and Cell Biology Objectives Troponin
More informationOriginal Article Clinical study of H-FABP for risk stratification and prognosis in patients with early ctnt-negative ACS
Int J Clin Exp Med 2017;10(3):4873-4880 www.ijcem.com /ISSN:1940-5901/IJCEM0046179 Original Article Clinical study of H-FABP for risk stratification and prognosis in patients with early ctnt-negative ACS
More informationImpact of Aging on High-sensitivity Cardiac Troponin T in Patients Suspected of Acute Myocardial Infarction
doi: 10.2169/internalmedicine.8510-16 http://internmed.jp ORIGINAL ARTICLE Impact of Aging on High-sensitivity Cardiac Troponin T in Patients Suspected of Acute Myocardial Infarction Taro Ichise, Hayato
More informationEDUCATIONAL COMMENTARY UNDERSTANDING THE BENEFITS AND CHALLENGES OF HIGH- SENSITIVITY TROPONIN TESTING IN CLINICAL AND PATHOLOGY SETTINGS
SENSITIVITY TROPONIN TESTING IN CLINICAL AND PATHOLOGY SETTINGS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE
More informationSpeaker: Richard Heitsman, MICT, C-POC-AACC. Title: National Account Manager/Clinical Cardiac Specialist-Radiometer America.
Speaker: Richard Heitsman, MICT, C-POC-AACC Title: National Account Manager/Clinical Cardiac Specialist-Radiometer America. Upon completion the participant will be able to o Review current and evolving
More informationPeri-operative Troponin Measurements - Pathophysiology and Prognosis
Peri-operative Troponin Measurements - Pathophysiology and Prognosis Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory
More informationAvailable online at
152 Available online at www.annclinlabsci.org Annals of Clinical & Laboratory Science, vol. 45, no. 2, 2015 The Distribution of Abbott High-Sensitivity Troponin I Levels in Korean Patients with Chest Pain
More informationUse of Biomarkers for Detection of Acute Myocardial Infarction
Use of Biomarkers for Detection of Acute Myocardial Infarction Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory Medicine
More informationTopic. Updates on Definition of Myocardial Infarction
Topic Updates on Definition of Myocardial Infarction In the past, general consensus for MI? Definition of MI by WHO - Combination of 2 of 3 characteristics - 1. Typical Symptoms 2. Enzyme Rise 3. Typical
More informationMario Plebani University-Hospital of Padova, Italy
Mario Plebani University-Hospital of Padova, Italy CK-MB mass assay CHF guidelines use BNP for rule out AST in AMI CK in AMI INH for CK-MB electrophoresis for CK and LD isoenzymes RIA for myoglobin WHO
More informationTable. Analytical characteristics of commercial and research cardiac troponin I and T assays declared by the manufacturer.
Table. Analytical characteristics of commercial and research cardiac troponin I and T assays declared by the manufacturer. Commercially available assays - Company/ platform(s)/ assay LoB a LoD b 99 th
More information7/31/2018. Overview of Next Generation Cardiac Troponin T High Sensitivity. Disclosures. Course Objectives: high sensitive Troponin T assay
Overview of Next Generation Cardiac Troponin T High Sensitivity Arleen Francis Medical & Scientific Liaison Roche Diagnostics 1 Disclosures Arleen Francis is an employee of Roche Diagnostics and a member
More informationAssays Pros and Cons AACB 2013 GOLD COAST QUEENSLAND AUSTRALIA
Highly Sensitive Versus Sensitive Troponin Assays Pros and Cons AACB 2013 GOLD COAST QUEENSLAND AUSTRALIA Robert H. Christenson, Ph.D., DABCC, FACB 2013 AACC President Professor of Pathology Professor
More informationRECOMMENDATIONS FOR USE OF POINT-OF- CARE TROPONIN ASSAYS IN ASSESSMENT OF ACUTE CORONARY SYNDROME
RECOMMENDATIONS FOR USE OF POINT-OF- CARE TROPONIN ASSAYS IN ASSESSMENT OF ACUTE CORONARY SYNDROME Dr Philip Tideman on behalf of Troponin Working Party Troponin PoCT Working Party Louise Cullen (ACEM)
More informationTROPONINS HAVE THEY CHANGED YOUR
TROPONINS HAVE THEY CHANGED YOUR PRACTICE THIS WEEK? Harvey White John Neutze Scholar Green Lane Cardiovascular Service and Cardiovascular Research Unit Auckland City Hospital, Auckland, New Zealand Disclosure
More informationTroponin when is an assay high sensitive?
Troponin when is an assay high sensitive? Professor P. O. Collinson MA MB BChir FRCPath FRCP edin MD FACB EurClin Chem Consultant Chemical Pathologist and Professor of Cardiovascular Biomarkers, Departments
More informationRapid exclusion of acute myocardial infarction in patients with undetectable troponin using a sensitive troponin I assay
Original Article Annals of Clinical Biochemistry 2015, Vol. 52(5) 543 549! The Author(s) 2015 Reprints and permissions: sagepub.co.uk/journalspermissions.nav DOI: 10.1177/0004563215576976 acb.sagepub.com
More informationAnalytical performance of the i-stat cardiac troponin I assay
Clinica Chimica Acta 345 (2004) 123 127 www.elsevier.com/locate/clinchim Analytical performance of the i-stat cardiac troponin I assay Fred S. Apple a, *, MaryAnn M. Murakami a, Robert H. Christenson b,
More informationThe state-of-the-art of high-sensitivity immunoassay for measuring cardiac troponin I and T
Editorial Page 1 of 5 The state-of-the-art of high-sensitivity immunoassay for measuring cardiac troponin I and T Aldo Clerico 1, Giuseppe Lippi 2 1 Scuola Superiore Sant Anna and Fondazione CNR Regione
More informationTroponin Assessment. Does it Carry Clinical Message? Stefan Blankenberg. University Heart Center Hamburg
Biomarkers for Optimal Management of Heart Failure Troponin Assessment Does it Carry Clinical Message? Stefan Blankenberg University Heart Center Hamburg Congress of the European Society of Cardiology
More informationACCESS hstni SCIENTIFIC LITERATURE
ACCESS hstni SCIENTIFIC LITERATURE 2017 2018 Table of contents Performance Evaluation of Access hstni A critical evaluation of the Beckman Coulter Access hstni: Analytical performance, reference interval
More informationMyocardial injury, necrosis and infarction
Myocardial injury, necrosis and infarction Harvey White Green Lane Cardiovascular Service and Cardiovascular Research Unit Auckland City Hospital, Auckland, New Zealand Faculty Disclosure In accordance
More informationClinical Investigations
Clinical Investigations Prognostic Implications of Low Level Cardiac Troponin Elevation Using High-Sensitivity Cardiac Troponin T Address for correspondence: Marc P. Bonaca, MD TIMI Study Group/Cardiovascular
More informationDefining rise and fall of cardiac troponin values
Defining rise and fall of cardiac troponin values Doable but Not Simple Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory
More informationExpert Consensus Document
Expert Consensus Document Universal Definition of Myocardial Infarction Kristian Thygesen; Joseph S. Alpert; Harvey D. White; on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of
More informationEssam Mahfouz, MD. Professor of Cardiology, Mansoura University
By Essam Mahfouz, MD. Professor of Cardiology, Mansoura University Agenda Definitions Classifications Epidemiology Risk stratification What is new? What is MI? Myocardial infarction is the death of part
More information10 Ways to Make the Use of High Sensitivity Cardiac Troponin Values Easier and Better
10 Ways to Make the Use of High Sensitivity Cardiac Troponin Values Easier and Better Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department
More informationEarly diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease usingmoresensitivecardiactroponinassays
European Heart Journal (2012) 33, 988 997 doi:10.1093/eurheartj/ehr376 CLINICAL RESEARCH Coronary artery disease Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery
More informationWhat can we learn from EQAs and audits for cardiac marker testing?
What can we learn from EQAs and audits for cardiac marker testing? Dr P. O. Collinson MA MB BChir FRCPath MD FACB Consultant Chemical Pathologist and Director of Clinical Blood Sciences, Head of Vascular
More informationConference Paper Small Changes in Cardiac Troponin Levels Are Common in Patients with Myocardial Infarction: Diagnostic Implications
Conference Papers in Medicine, Article ID 583175, 5 pages http://dx.doi.org/10.1155/2013/583175 Conference Paper Small Changes in Cardiac Troponin Levels Are Common in Patients with Myocardial Infarction:
More information9/18/2017. Disclosures. Cardiac Troponin: ER Utilization and the Next Generation
Disclosures Cardiac Troponin: ER Utilization and the Next Generation Joshua Soldo is an employee of Roche Diagnostics within the division of Medical Scientific Affairs. Data presented is intended for purely
More informationThe Diagnostic Value of Troponin T and Myoglobin Levels in Acute Myocardial Infarction: a Study in Turkish Patients
The Journal of International Medical Research 2003; 31: 76 83 The Diagnostic Value of Troponin T and Myoglobin Levels in Acute Myocardial Infarction: a Study in Turkish Patients S VATANSEVER 1, V AKKAYA
More informationEpidemiology and Prevention
Epidemiology and Prevention Mortality and Readmission of Patients With Heart Failure, Atrial Fibrillation, or Coronary Artery Disease Undergoing Noncardiac Surgery An Analysis of 38 047 Patients Sean van
More informationDiagnostic Implications of an Elevated Troponin in the Emergency Department
Diagnostic Implications of an Elevated Troponin in the Emergency Department The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation
More informationA comprehensive review of upper reference limits reported for (high-)sensitivity cardiac troponin assays: the challenges that lie ahead
Clin Chem Lab Med 2012;50(5):791 806 2012 by Walter de Gruyter Berlin Boston. DOI 10.1515/cclm-2011-0895 Review A comprehensive review of upper reference limits reported for (high-)sensitivity cardiac
More informationGUIDELINES FOR TROPONIN TESTING: AN EVIDENCE-BASED APPROACH TO DIAGNOSIS AND TREATMENT OF THE ACS PATIENT
GUIDELINES FOR TROPONIN TESTING: AN EVIDENCE-BASED APPROACH TO DIAGNOSIS AND TREATMENT OF THE ACS PATIENT sponsored by TROPONIN OVERVIEW TROPONIN DETECTION IN NORMAL AND DISEASE STATES1 The detection of
More informationBIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS. As. MARUSHCHAK M.I.
BIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS As. MARUSHCHAK M.I. Heart attack symptoms Acute MI Measurement of cardiac enzyme levels Measure cardiac enzyme levels at regular
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL S1 SUPPLEMENTAL MATERIAL to Chromogranin B in Heart Failure: a Putative Cardiac Biomarker Expressed in the Failing Myocardium Helge Røsjø MD 1,2,3 ; Cathrine Husberg MSc, PhD 2,4
More informationDIAGNOSTICS ASSESSMENT PROGRAMME
DIAGNOSTICS ASSESSMENT PROGRAMME Evidence overview Early rule out or diagnosis of acute myocardial infarction: High-sensitivity troponin tests (Elecsys troponin T high-sensitive, ARCHITECT STAT highsensitivity
More informationKeywords Acute coronary syndromes, High sensitivity cardiac markers, Malta, Troponin T, Myocardial infarction
Did the introduction of high-sensitivity Troponin T for the assessment of suspected acute coronary syndrome in Malta result in reduction of hospitalization time? A retrospective review Ahmed Chilmeran,
More informationBetter, higher, lower, faster: increasingly rapid clinical decision making using high-sensitivity cardiac troponin assays
Editorial Page 1 of 5 Better, higher, lower, faster: increasingly rapid clinical decision making using high-sensitivity cardiac troponin assays Noreen van der Linden, Alexander S. Streng, Will K. W. H.
More informationSensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction
The new england journal of medicine original article Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction Till Keller, M.D., Tanja Zeller, Ph.D., Dirk Peetz, M.D., Stergios Tzikas,
More informationP1: OTE/SPH P2: OTE BLUK084-Adams April 13, :13 PART 1. Cardiac troponins
PART 1 Cardiac troponins 1 2 CHAPTER 1 Basics of cardiac troponin: practical aspects of assays, potential analytical confounders, and clinical interpretation Fred S. Apple Case 1 Following an episode of
More informationThe Chest Pain Choice Decision Aid A Randomized Trial
The Chest Pain Choice Decision Aid A Randomized Trial Erik P. Hess, MD; Meghan A. Knoedler, RN; Nilay D. Shah, PhD; Jeffrey A. Kline, MD; Maggie Breslin, MDes; Megan E. Branda, MS; Laurie J. Pencille,
More informationhs-c Tn I high sensitivity troponin I <17 min
hs-c Tn I high sensitivity troponin I IFCC & ESC compliant 0/ h NSTEMI rule-out / rule-in algorithm POCT whole blood/plasma Results in < 7 minutes
More informationA. BISOC 1,2 A.M. PASCU 1 M. RĂDOI 1,2
Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 5 (54) No. 2-2012 THE ctntg4 PLASMA LEVELS IN RELATION TO ELECTROCARDIOGRAPHIC AND ECHOCARDIOGRAPHIC ABNORMALITIES IN
More informationPost-Procedural Myocardial Injury or Infarction
Post-Procedural Myocardial Injury or Infarction Hugo A Katus MD & Evangelos Giannitsis MD Abteilung Innere Medizin III Kardiologie, Angiologie, Pulmologie Universitätsklinikum Heidelberg Conflict of Interest:
More information13. RECOMMENDATIONS ON USE OF BIOCHEMICAL MARKERS IN ACUTE CORONARY SYNDROME: IFCC PROPOSALS
13. RECOMMENDATIONS ON USE OF BIOCHEMICAL MARKERS IN ACUTE CORONARY SYNDROME: IFCC PROPOSALS Prof. Mauro Panteghini, MD, Ph.D. Chairman of the IFCC Committee on Standardization of Markers of Cardiac Damage
More informationCardiac Troponin: Current Status and Future Promise
Cardiac Troponin: Current Status and Future Promise Robert H. Christenson, Ph.D., ABCC, FACB Professor of Pathology Professor of Medical and Research Technology University of Maryland School of Medicine
More informationPreparing the United States for High-Sensitivity Cardiac Troponin Assays
Journal of the American College of Cardiology Vol. 61, No. 17, 2013 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.09.069
More informationIFCC Task Force on Clinical Applications of Cardiac Biomarkers (TF-CB) Report to the General Conference 2016 Madrid
IFCC Task Force on Clinical Applications of Cardiac Biomarkers (TF-CB) Report to the General Conference 2016 Madrid 1 CREATED By the EB in 2011, following to the Committee on Standardization of Cardiac
More informationShihui Fu 1,2, Rongjie Jin 2, Leiming Luo 1* and Ping Ye 1*
Fu et al. Nutrition & Metabolism (2017) 14:73 DOI 10.1186/s12986-017-0229-8 RESEARCH Open Access Baseline type 2 diabetes had a significant association with elevated high sensitivity cardiac troponin T
More informationUniversal Definition of Myocardial Infarction
Journal of the American College of Cardiology 2007 by the European Society of Cardiology, the American College of Cardiology Foundation, the American Heart Association, and the World Heart Federation Published
More informationComparison of conventional and highly-sensitive troponin I measurement in ultra-marathon runners
J Thromb Thrombolysis (2012) 33:338 342 DOI 10.1007/s19-011-0651-0 Comparison of conventional and highly-sensitive troponin I measurement in ultra-marathon runners Giuseppe Lippi Federico Schena Gian Luca
More informationRecent advances in point-of-care diagnostics
Alan H.B. Wu In this Issue: Focusing on POCT Recent advances in point-of-care diagnostics for cardiac markers Alan H.B. Wu, Ph.D. Department of Laboratory Medicine, University of California, San Francisco
More informationPeter A. Kavsak, 1* Andrew R. MacRae, 2 Glenn E. Palomaki, 3 Alice M. Newman, 4 Dennis T. Ko, 4 Viliam Lustig, 2 Jack V. Tu, 4 and Allan S.
Clinical Chemistry 52:11 2028 2035 (2006) Evidence-Based Laboratory Medicine and Test Utilization Health Outcomes Categorized by Current and Previous Definitions of Acute Myocardial Infarction in an Unselected
More informationACUTE MYOCARDIAL INFARCTION: DEFINITION, DIAGNOSIS, AND THE EVOLUTION OF CARDIAC MARKERS
ACUTE MYOCARDIAL INFARCTION: DEFINITION, DIAGNOSIS, AND THE EVOLUTION OF CARDIAC MARKERS d Copyright 2018 by. LEARNING OBJECTIVES: 1. Define MI and the challenges in MI diagnosis 2. Define the current
More informationOriginal Article Role of high-sensitivity cardiac troponin in the early accurate diagnosis of peri-operative acute myocardial infarction
Int J Clin Exp Med 2017;10(9):13463-13472 www.ijcem.com /ISSN:1940-5901/IJCEM0048280 Original Article Role of high-sensitivity cardiac troponin in the early accurate diagnosis of peri-operative acute myocardial
More informationCardiac-specific troponin I (ctni) has been under intensive
Original Articles Association of Mild Transient Elevation of Troponin I Levels With Increased Mortality and Major Cardiovascular Events in the General Patient Population G. Steinar Gudmundsson, MD; Stephen
More informationImaging. High-Sensitivity Troponin T Concentrations in Acute Chest Pain Patients Evaluated With Cardiac Computed Tomography
Imaging High-Sensitivity Troponin T Concentrations in Acute Chest Pain Patients Evaluated With Cardiac Computed Tomography James L. Januzzi, Jr, MD; Fabian Bamberg, MD, MPH; Hang Lee, PhD; Quynh A. Truong,
More informationAcute Coronary Syndromes
High-sensitivity Troponins Difficult Friends in Acute Coronary Syndromes Roland Klingenberg, Christian M Matter, 2 Christophe Wyss, Danielle Hof, Arnold von Eckardstein and Thomas F Lüscher 6. Clinical
More informationAnalytical Characteristics of High-Sensitivity Cardiac Troponin Assays
Clinical Chemistry 58:1 54 61 (2012) Mini-Reviews Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays Fred S. Apple 1,2* and Paul O. Collinson, 3 for the IFCC Task Force on Clinical
More informationCongreso Nacional del Laboratorio Clínico 2016
Can biomarkers help us make a better use of cardiac imaging for myocardial ischaemia rule-out in the Emergency Department? Alessandro Sionis Director Acute and Intensive Cardiac Care Unit Hospital de la
More informationWaiting for High-Sensitivity POCT Cardiac Troponin Assays: Clinical and Analytical Needs I Have a Pain in My Chest That Hurts Very Bad
Waiting for High-Sensitivity POCT Cardiac Troponin Assays: Clinical and Analytical Needs I Have a Pain in My Chest That Hurts Very Bad Fred Apple PhD Hennepin County Medical Center University of Minnesota
More informationPost Operative Troponin Leak: David Smyth Christchurch New Zealand
Post Operative Troponin Leak: Does It Really Matter? David Smyth Christchurch New Zealand Life Was Simple Once Transmural Infarction Subendocardial Infarction But the Blood Tests Were n t Perfect Creatine
More informationA new, precise definition of acute myocardial infarction
REVIEW CME CREDIT EDUCATIONAL OBJECTIVES: Readers will understand the new definition of acute myocardial infarction (MI) and how to make the diagnosis of acute MI SHAUN SENTER, MD, MS Department of Cardiovascular
More informationFactors Influencing the 99th Percentile of Cardiac Troponin I Evaluated in Community-Dwelling Individuals at 70 and 75 Years of Age
Papers in Press. Published March 5, 2013 as doi:10.1373/clinchem.2012.196634 The latest version is at http://hwmaint.clinchem.org/cgi/doi/10.1373/clinchem.2012.196634 Clinical Chemistry 59:7 000 000 (2013)
More informationAcute Coronary Syndrome
ACUTE CORONOARY SYNDROME, ANGINA & ACUTE MYOCARDIAL INFARCTION Administrative Consultant Service 3/17 Acute Coronary Syndrome Acute Coronary Syndrome has evolved as a useful operational term to refer to
More informationBioRemarkable Symposium
BACC BioRemarkable Symposium Acute Myocardial infarction Stefan Blankenberg University Heart Center Hamburg London, September 7th, 2017 Universitätsklinikum Hamburg-Eppendorf Third Universal-Definition
More informationREVISED MI DEFINITIONS IMPLICATIONS FOR CLINICAL TRIALS. Maarten L Simoons Thoraxcenter - Erasmus MC Rotterdam - The Netherlands
REVISED MI DEFINITIONS IMPLICATIONS FOR CLINICAL TRIALS Maarten L Simoons Thoraxcenter - Erasmus MC Rotterdam - The Netherlands TRITON Prasugrel ACS + PCI n = 13,608 moderate / high risk ACS, all PCI p
More informationDuring the past 2 decades cardiac troponin (ctn) has
High-Sensitivity Cardiac Troponin T Compared With Standard Troponin T Testing on Emergency Department Admission: How Much Does It Add in Everyday Clinical Practice? Angelika Hammerer-Lercher, MD;* Thomas
More informationEvaluating temporal trends in the incidence and outcome
Epidemiology and Prevention Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial Infarction Véronique L. Roger, MD, MPH; Susan A. Weston, MS; Yariv Gerber, PhD; Jill M. Killian, BS; Shannon
More informationThe Chest Pain Choice Decision Aid A Randomized Trial
The Chest Pain Choice Decision Aid A Randomized Trial Erik P. Hess, MD; Meghan A. Knoedler, RN; Nilay D. Shah, PhD; Jeffrey A. Kline, MD; Maggie Breslin, MDes; Megan E. Branda, MS; Laurie J. Pencille,
More informationHigh Sensitivity Troponin Improves Management. But Not Yet
High Sensitivity Troponin Improves Management But Not Yet Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory Medicine
More informationIntroduction. Review. Petr Jarolim* High sensitivity cardiac troponin assays in the clinical laboratories
Clin Chem Lab Med 2015; 53(5): 635 652 Review Petr Jarolim* High sensitivity cardiac troponin assays in the clinical laboratories DOI 10.1515/cclm-2014-0565 Received May 27, 2014; accepted July 24, 2014;
More informationTROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained?
TROPONIN POSITIVE WHAT DOES IT MEAN? Frequently Asked Questions Regarding the Use of Troponin in the Clinical Setting What does an elevated troponin level mean? Elevated troponin is a sensitive and specific
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationMyocardial Infarction
Myocardial Infarction MI = heart attack Defined as necrosis of heart muscle resulting from ischemia. A very significant cause of death worldwide. of these deaths, 33% -50% die before they can reach the
More informationHigh-sensitivity cardiac troponin I immunoassay reduces the chance of patient misclassification in the emergency department
Original Article Page 1 of 5 High-sensitivity cardiac troponin I immunoassay reduces the chance of patient misclassification in the emergency department Giuseppe Lippi 1, Fabian Sanchis-Gomar 2,3,4, Rosalia
More informationNews. Laboratory. CHANGES IN CARDIAC TROPONIN I REPORTING Gene Shaw, MD, Annu Khajuria, PhD. Inside This Issue
Laboratory News Inside This Issue CHANGES IN CARDIAC TROPONIN I REPORTING...1 FOUR NEW SEROLOGY TESTS FOR AUTOIMMUNE LIVER DISEASES...3 INSULIN LIKE GROWTH FACTOR-1 (IGF-1) METHOD CHANGES...6 CHANGES IN
More informationTroponin I Measurement: Evolution of a Biomarker Essential for Assessment of Myocardial Injury
Troponin I Measurement: Evolution of a Biomarker Essential for Assessment of Myocardial Injury Robert H. Christenson, Ph.D., DABCC, FACB Professor of Pathology Professor of Medical and Research Technology
More informationHigh-Sensitivity Cardiac Troponin in Suspected ACS
15 th Annual Biomarkers in Heart Failure and Acute Coronary Syndromes STATE-OF-THE-ART High-Sensitivity Cardiac Troponin in Suspected ACS David A. Morrow, MD, MPH Director, Levine Cardiac Intensive Care
More information